Connect with Us

KVNF DJs- We love you!

Rob Stein

Maggie StarbardNPR

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

And I'm Robert Siegel. The first case of MERS has been confirmed in the U.S. MERS stands for Middle East Respiratory Virus Syndrome. Health officials say a man in Indiana was hospitalized on Monday and is in stable condition. NPR's Rob Stein reports that while precautions are being taken to contain the virus, there is no reason for widespread alarm.

Scientists reported Thursday they had figured out a way to make primitive human sperm out of skin cells, an advance that could someday help infertile men have children.

"I probably get 200 emails a year from people who are infertile, and very often the heading on the emails is: Can you help me?" says Renee Reijo Pera of Montana State University, who led the research when she was at Stanford University.

2:16 pm

Tue April 22, 2014

A key government panel Tuesday voted unanimously against approval of a powerful opioid prescription painkiller intended to provide faster relief with fewer side effects.

At the conclusion of a hearing, the Food and Drug Administration advisory committee voted 14-0 against recommending that the agency approve Moxduo, the first drug to combine morphine and oxycodone into one capsule.

Shots - Health News

1:29 am

Tue April 22, 2014

Morphine and oxycodone (the active ingredient in Oxycontin) are strong narcotic pain relievers on their own. Moxduo, a drug now up for FDA approval, would combine morphine and oxycodone in a single capsule.

The Food and Drug Administration is trying to decide whether to approve a powerful new prescription painkiller that's designed to relieve severe pain quickly, and with fewer side effects than other opioids.

While some pain experts say the medicine could provide a valuable alternative for some patients in intense pain, the drug (called Moxduo) is also prompting concern that it could exacerbate the epidemic of abuse of prescription painkillers and overdoses.

Ever since the day Garrett Peterson was born, his parents have had to watch him suddenly just stop breathing.

"He could go from being totally fine to turning blue sometimes β not even kidding β in 30 seconds," says Garrett's mother, Natalie Peterson, 25, of Layton, Utah. "It was so fast. It was really scary."

A panel of government advisers has expressed serious concerns about a controversial proposal to allow scientists to try to make babies using eggs that have been genetically altered to include DNA from another woman.

Members of the Food and Drug Administration panel said they were worried that not enough research has been done to know whether the experiments would be safe.

More than 60 percent of flu patients who ended up in the hospital this year have been between the ages of 18 and 64. The proportion of young people among the hospitalized is much higher than usual, according to the federal Centers for Disease Control and Prevention. Only about 35 percent of flu patients who were hospitalized in the previous three years fell into that age group, the CDC says.

A lot of parents like to think their kids will simply outgrow baby fat. But the risk of becoming a severely overweight adult can actually start as early as kindergarten, research suggests.

"As parents, as a society, as clinicians, we need to think about a healthy weight really early on," says Solveig Cunningham, who led the study. But that doesn't mean putting young children on calorie-restricted diets.

When Melissa Shenewa and her husband imagined their first weeks with their new baby, they pictured hours of cuddling. Instead, they're enduring hours of inconsolable crying.

Their 6-week-old son, Aladdin, is a colicky baby. He cries for hours, usually in the middle of the night. They've tried everything they could think of. Nothing helps.

"Being a parent when your child is screaming in pain for hours on end and there's nothing you can do, you feel helpless," says Shenewa, 24, who lives in Houston. "You feel like you're not a good parent."

Mon November 18, 2013

Could the microbes that inhabit our guts help explain that old idea of "gut feelings?" There's growing evidence that gut bacteria really might influence our minds.

"I'm always by profession a skeptic," says Dr. Emeran Mayer, a professor of medicine and psychiatry at the University of California, Los Angeles. "But I do believe that our gut microbes affect what goes on in our brains."

Here's possible solace for parents who are up at night with a baby who gets sick all the time: There appears to be a good reason why infant immune systems don't fight off germs.

A newborn's immune system is deliberately not doing battle with every germ that comes along so that "good" microbes have a chance to settle in, researchers say. That explanation is at odds with the widely held belief that those new immune systems are just too weak to do the job.